Skip to content
HowShorted

MADRIGAL PHARMACEUTICALS, INC. short interest in 2024

In 2024, MADRIGAL PHARMACEUTICALS, INC.'s disclosed short interest ran from 16.74% of shares outstanding on 12 Jan 2024 to 18.83% on 31 Dec 2024, a change of +2.09 percentage points. The year's high was 24.54% on 31 May 2024 and its low 15.92% on 31 Jan 2024, averaging 18.68% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.00 days on 30 Aug 2024. Full history: MADRIGAL PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for MADRIGAL PHARMACEUTICALS, INC. in 2024

2024 in figures

Start of year
16.74% (12 Jan 2024)
End of year
18.83% (31 Dec 2024)
Change
+2.09 pp
High
24.54% (31 May 2024)
Low
15.92% (31 Jan 2024)
Average
18.68%
Highest days to cover
20.00 (30 Aug 2024)
SEC filings marked
8

Every report in 2024

MADRIGAL PHARMACEUTICALS, INC. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202416.74%11.14
31 Jan 202415.92%11.32
15 Feb 202417.16%4.02
29 Feb 202417.55%6.9510-K filed, results (8-K)
15 Mar 202416.52%3.87
28 Mar 202417.03%6.19
15 Apr 202417.25%9.88
30 Apr 202420.16%8.67
15 May 202419.56%9.9410-Q filed, results (8-K)
31 May 202424.54%13.16
14 Jun 202420.81%5.62
28 Jun 202419.13%10.05
15 Jul 202419.27%16.28
31 Jul 202417.28%14.10
15 Aug 202417.29%9.7710-Q filed, results (8-K)
30 Aug 202417.31%20.00
13 Sep 202417.17%17.89
30 Sep 202417.79%13.81
15 Oct 202418.66%14.36
31 Oct 202420.78%12.5010-Q filed, results (8-K)
15 Nov 202420.33%5.41
29 Nov 202419.63%11.33
13 Dec 202421.71%16.04
31 Dec 202418.83%12.63

See also: MADRIGAL PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.